20 Results

People

  1. Heller
    Heller
  2. O'Reilly
    O'Reilly
  3. Kernan
    Kernan
  4. Small
    Small
  5. Papadopoulos
    Papadopoulos
  6. Black
    Black
  7. Boulad
    Boulad
  8. Castro-Malaspina
    Castro-Malaspina
  9. Young
    Young
  10. Collins
    Collins

Groups

  1. Biostatistics Service (20)
  2. Epidemiology and Biostatistics (20)
  3. Department of Medicine (17)
  4. Center for Hematologic Malignancies (15)
  5. GSK Faculty (13)
  6. Hematologic Malignancies, Division of (13)
  7. Tow Center for Developmental Oncology (TCDO) (13)
  8. Sloan Kettering Institute Faculty (12)
  9. Pediatrics, Department of (11)
  10. Stem Cell Transplantation and Cellular Therapy Service (11)
  1. "acute granulocytic leukemia"
  2. "Biostatistics Service"
Formats
  1. Journal Article (20)
Groups
  1. Biostatistics Service (20)
  2. Epidemiology and Biostatistics (20)
  3. Department of Medicine (17)
  4. Center for Hematologic Malignancies (15)
  5. GSK Faculty (13)
  6. Hematologic Malignancies, Division of (13)

More Groups

People
  1. Glenn Heller (12)
  2. Richard O'Reilly (9)
  3. Farid Boulad (7)
  4. Nancy Kernan (7)
  5. Trudy Small (6)
  6. Esperanza Papadopoulos (5)

More People

Years
  1. 2015 (1)
  2. 2014 (1)
  3. 2012 (3)
  4. 2010 (1)
  5. 2008 (3)
  6. 2007 (2)

More Years

Publications
  1. Blood (4)
  2. Bone Marrow Transplantation (4)
  3. Biology of Blood and Marrow Transplantation (3)
  4. Clinical Cancer Research (2)
  5. British Journal of Haematology (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Hematology (4)
  2. Nature Publishing Group (4)
  3. Elsevier Inc. (3)
  4. American Association for Cancer Research (2)
  5. John Wiley & Sons (2)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program
    Journal Article

    Park, S. M.; Gönen, M.; Vu, L.; Minuesa, G.; Tivnan, P.; Barlowe, T. S.; Taggart, J.; Lu, Y.; Deering, R. P.; Hacohen, N.; more...
    Journal of Clinical Investigation (2015)

    Fulltext@MSK | Save
  • Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma
    Journal Article

    Dahi, P. B.; Tamari, R.; Devlin, S. M.; Maloy, M.; Bhatt, V.; Scordo, M.; Goldberg, J.; Zelenetz, A. D.; Hamlin, P. A.; Matasar, M. J.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900
    Journal Article

    Gonen, M.; Sun, Z.; Figueroa, M. E.; Patel, J. P.; Abdel-Wahab, O.; Racevskis, J.; Ketterling, R. P.; Fernandez, H.; Rowe, J. M.; Tallman, M. S.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromes
    Journal Article

    Klimek, V. M.; Dolezal, E. K.; Tees, M. T.; Devlin, S. M.; Stein, K.; Romero, A.; Nimer, S. D.
    Leukemia Research (2012)

    Fulltext@MSK | Save
  • Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
    Journal Article

    Patel, J. P.; Gonen, M.; Figueroa, M. E.; Fernandez, H.; Sun, Z.; Racevskis, J.; Van Vlierberghe, P.; Dolgalev, I.; Thomas, S.; Aminova, O.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save
  • Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Divgi, C. R.; Panageas, K. S.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Sgouros, G.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (Romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes
    Journal Article

    Klimek, V. M.; Fircanis, S.; Maslak, P.; Guernah, I.; Baum, M.; Wu, N.; Panageas, K.; Wright, J. J.; Pandolfi, P. P.; Nimer, S. D.
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia
    Journal Article

    Chaudhury, S.; Auerbach, A. D.; Kernan, N. A.; Small, T. N.; Prockop, S. E.; Scaradavou, A.; Heller, G.; Wolden, S.; O'Reilly, R. J.; Boulad, F.
    British Journal of Haematology (2008)

    Fulltext@MSK | Save
  • Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings
    Journal Article

    Castro-Malaspina, H.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K.; Chiu, M.; more...
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies
    Journal Article

    Small, T. N.; Young, J. W.; Castro-Malaspina, H.; Prockop, S.; Wilton, A.; Heller, G.; Boulad, F.; Chiu, M.; Hsu, K.; Jakubowski, A.; more...
    Biology of Blood and Marrow Transplantation (2007)

    Fulltext@MSK | Save